WCM
AGN

Windsor Capital Management’s Allergan plc AGN Stock Holding History

Windsor Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200
Closed -$34K – 331
2013
Q4 		$34K Hold
200
– – 0.02% 207
2013
Q3 		$29K Hold
200
– – 0.02% 236
2013
Q2 		$25K Buy
+200
New +$22.6K 0.02% 244

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Windsor Capital Management's AGN Position: Q1 2014 in Review

Windsor Capital Management sold out of Allergan plc (AGN) in Q1 2014, closing a stake of 200 shares — an estimated $34K sold.

Windsor Capital Management first reported a position in AGN in Q2 2013 and held it in 3 quarters. The position peaked at $34K in Q4 2013. 628 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • Windsor Capital Management reported no remaining Allergan plc position as of Q1 2014 after selling out during the quarter.
  • Windsor Capital Management sold 200 Allergan plc shares in Q1 2014, an estimated $34K.
  • Windsor Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 3 quarters.
  • Windsor Capital Management's Allergan plc position peaked at $34K in Q4 2013.
  • 628 funds tracked by Wall St. Rank held Allergan plc as of Q1 2014.

Based on Windsor Capital Management's 13F filing for Q1 2014, filed 28 Apr 2014.